The risks to the prostate of testosterone replacement therapy for late-onset hypogonadism "may not be as great as once believed"

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1130, 2006-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risks of testosterone replacement therapy in ageing men

By Tan R   Salazar J  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 599-606

Informa Healthcare

Access to resources Recommend Favorite

Testosterone replacement therapy: what are the risks?

By  

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Evidence-based Medicine Update on Testosterone Replacement Therapy (TRT) in Male Hypogonadism: Focus on New Formulations

By  

Current Pharmaceutical Design, Vol. 17, Iss. 15, 2011-05 ,pp. : 1500-1511

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of testosterone replacement therapy

By Zitzmann Michael  

Pharmacogenomics, Vol. 10, Iss. 8, 2009-08 ,pp. : 1341-1349

Future Medicine

Access to resources Recommend Favorite

Testosterone: Its Role in Development of Prostate Cancer and Potential Risk From Use as Hormone Replacement Therapy

By Slater S.   Oliver R.T.D.  

Drugs & Aging, Vol. 17, Iss. 6, 2000-12 ,pp. : 431-439

Adis International

Access to resources Recommend Favorite